Acadia Healthcare (NASDAQ:ACHC) Price Target Lowered to $91.00 at Barclays

Acadia Healthcare (NASDAQ:ACHC) had its price objective decreased by Barclays from $100.00 to $91.00 in a research report released on Thursday morning, Benzinga reports. Barclays currently has an overweight rating on the stock.

Several other equities analysts have also recently issued reports on the company. UBS Group lifted their price objective on Acadia Healthcare from $88.00 to $102.00 and gave the company a buy rating in a research note on Wednesday, February 28th. Cantor Fitzgerald reiterated a neutral rating and issued a $90.00 price target on shares of Acadia Healthcare in a research note on Tuesday, March 5th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a sell rating to a hold rating and set a $70.00 price target for the company in a report on Thursday, April 25th. Stephens raised shares of Acadia Healthcare from an equal weight rating to an overweight rating and set a $92.00 price objective for the company in a research report on Friday, January 5th. Finally, Mizuho boosted their target price on shares of Acadia Healthcare from $77.00 to $84.00 and gave the stock a neutral rating in a research note on Wednesday, March 6th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of Moderate Buy and an average price target of $89.50.

Acadia Healthcare Stock Down 0.9 %

ACHC traded down $0.61 during trading hours on Thursday, hitting $66.12. 1,181,258 shares of the company’s stock were exchanged, compared to its average volume of 604,466. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare has a 12-month low of $64.74 and a 12-month high of $87.77. The firm has a market cap of $6.11 billion, a P/E ratio of -472.29, a price-to-earnings-growth ratio of 2.15 and a beta of 1.31. The firm has a 50 day moving average of $77.13 and a 200 day moving average of $77.61.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, May 1st. The company reported $0.84 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. The business had revenue of $768.10 million for the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a positive return on equity of 11.56% and a negative net margin of 0.38%. The company’s revenue was up 9.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.75 earnings per share. Analysts predict that Acadia Healthcare will post 3.57 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the sale, the director now directly owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.00% of the company’s stock.

Institutional Trading of Acadia Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of ACHC. GAMMA Investing LLC acquired a new position in Acadia Healthcare in the 4th quarter valued at about $26,000. Headlands Technologies LLC purchased a new position in shares of Acadia Healthcare in the 3rd quarter valued at approximately $25,000. Mather Group LLC. acquired a new position in shares of Acadia Healthcare in the first quarter valued at approximately $48,000. Fifth Third Bancorp lifted its holdings in shares of Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after purchasing an additional 136 shares during the period. Finally, DekaBank Deutsche Girozentrale purchased a new position in Acadia Healthcare in the 3rd quarter valued at $96,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.